Skip to main content
. 2001 Jan 1;21(1):340–348. doi: 10.1523/JNEUROSCI.21-01-00340.2001

Table 4.

Mean (±SEM) number of prandial and nonprandial fluid lever bouts during each experimental phase

Experimental phase Prandial Nonprandial
KO WT KO WT
Phase 1
 Trials
  1–4 1.2  (0.2) 1.8  (0.3) 1.1  (0.2) 2.6  (0.7)
  5–8 1.0  (0.4) 2.3  (0.7) 1.1  (0.4) 1.8  (0.7)
  9–12 1.3  (0.4) 2.6  (0.7) 1.1  (0.6) 2.4  (0.9)
  13–16 2.1  (0.7) 3.9  (0.7) 1.4  (0.7) 3.5  (1.4)
  17–20 2.3  (0.7) 4.5  (1.1) 1.6  (0.6) 3.5  (1.2)
Phase 2
 Ethanol (% v/v)
  0 1.5  (0.3) 2.6  (0.6) 0.9  (0.4) 1.2  (0.3)
  5 2.3  (0.6) 3.7  (1.1) 1.5  (0.7) 2.5  (0.8)
  10 2.4  (0.7) 4.2  (1.0) 1.8  (0.8) 3.4  (1.2)
  20 2.2  (0.6) 6.0  (1.0) 1.1  (0.5) 3.6  (0.8)
  30 2.7  (0.5) 4.7  (0.6) 1.1  (0.4) 3.0  (0.8)
Phase 3
 Ethanol (% v/v)
  0 14.1  (4.1) 13.9  (2.2) 6.3  (0.8) 14.4  (3.2)
  5 11.3  (1.0) 16.2  (1.9) 8.8  (1.2) 15.7  (2.1)
  10 11.4  (0.9) 14.8  (2.1) 8.5  (0.8) 15.6  (2.5)
  20 9.6  (1.3) 13.4  (1.6) 5.9  (1.2) 10.3  (2.4)